A refmpective study of ten patients with myxomatous degeneration of cardiac valves revealed two patients with "floppy valve syndromen and eight patients with isolated myxomatous change of apparently diverse etiology. The myxomatous degeneration can be seen in a minor degree in normal valves and to a greater extent in clinical and experimental diseases of unknown etiology. The dBicnlties encormtered in the surgkal treatment of patients with mysomatous degeneration of the cardiac valves are related to the friability of the aorta and the valve annulns,
hile Marfanl first described musculoskeletal Wabnormalities and unusual elongation of extremities in a young patient, the first autopsy on a patient with the Marfan syndrome was done by Salle,2 who noted myxomatous change in the gross appearance of cardiac valves. Recently, Read and a s s~c i a t e s~.~ described myxomatous transformation of cardiac valves (floppy valve syndrome) without characteristic musculoskeletal or ocular stigmata of the Marfan syndrome in a group of patients. These patients had pure mitral or aortic ins&-ciency due to myxomatous degeneration without evidence of calcification, commissural disease, or inflammation. They were considered as formes frustes of the Marfan syndrome. Subsequent studies have validated their ~l a i m .~.~ A review of our own experience with ten patients showing myxomatous degeneration of cardiac valves is reported.
only those patients showing myxomatous degeneration of valves were selected. Eight cases were selected from a group of 400 patients who were operated upon, and two cases from a group of 3,200 patients who were subjected to autopsy. The interpretation of myxomatous degeneration of the mitral valve in one patient was confirmed by the Armed Forces Institute of Pathology. The other cases were not submitted because of the same histologic appearance. Subsequently, the histologic features of the affected valves were carefully compared with those of patients dying of noncardiac c a w .
The ten patients may be divided into two groups (group 1 and 2). The details of the patients are summarized in Table 1 . The first group (case 1 and 2) showed not only myxomatous transformation of the aortic valves and cystic medionecrosis of the aorta, but some of the musculoskeletal features of the Marfan syndrome. They were similar to the patients described by Read (Fig 1) . A No. 13 Starr-Edwards prosthesis was implanted. Patient continued to do well for more than a year after operation.
CA!~E 5
A 25-yew-old Negro man was admitted'to the hospital because of progressive dyspnea to aqstomed exertion. He was first seen 18 years prior to this admission and the diagnasis was rheumatic aortic incompetence. However, previous records failed to show evidence for rheumatic etiology. He was 73 inches tall and weighed 200 pounds. His blood pressure was 130/70 mm Hg. A diastolic thrill and a grade IV/(rI rumbling diastolic murmur were heard in the aortic area. There was also a grade 111 pansystolic murmur heard at the apex, which was conducted to the axilla. The liver was palpable two inches below the costal margin and there was minimal pedal pitting edema.
At operation, a large and dilated heart was seen. Both the aortic annulus and ascending aorta were greatly dilated. The mitral annulus was also greatly dilated. The aortic cusps were thin and prolapsed into the ventricle. The mitral tissue. Hemotoxylin and eosin staining, X 800.
The removed valw showed evidence of myxomatous de- There was moderate left ventricular enlargement seen at autopsy. The aortic and mitral valves showed redundant floppy ledeats. The posterior leaflet of the mitral valve was approximately three times the normal thickness and had a large bulbous mass at the free edge of the cusp. On the anterior l&t, there was an area of perforation about 0.4 cm in diameter. The chordae tendineae were thin and markedly stretched. Microscopically, the valve ledets showed myxomatous degeneration with marked loss of elastic fibers and increase in mucopolysaccharide ground substance and fibrous tissue. These findings were confirmed by the Armed Forces Institute of Pathology.
The patient lived a normal life span in spite of a 20 year history of mitral insufficiency. He was considered suffering from rheumatic mitral disease, but no evidence of previous rheumatic activity was present at any point in his course. The gross appearance and histologic picture were strikingly difterent from rheumatic valvular disease. The evidence of bacterial endocarditis is interesting in the light of known propensity for this disease in patients with the Marfan syndrome. McKusick thinks that myxomatous degeneration is the basis for that asso~iation.~ All patients in this study showed myxomatous transformation of aortic or mitral valves. The histologic appearance of myxomatous degeneration seen in group 1 or group 2 was indistinguishable from the other. In group 1, both patients had cystic medionecrosis of the aorta as well as stigmata of the Marfan syndrome. The similarity of myxomatous degeneration of the valve cusps to the medionecrosis in the aorta has been pointed out by Tobin and colleagues,7 Tung and Liebow,s and Castleman and Sprague.O In group 2, two patients had cystic medionecrosis of the aorta and myxomatous degeneration of the aortic valves without any stigmata of the Marfan syndrome. Though isolated Erdheim's cystic medie necrosis is apparently unrelated to the Marfan syndrome, the histologic appearance of the affected aortae are indi~tinguishable.~.~ Histologically, the same appearance is seen in the coarctation of the aorta,lO and in the Ehler-Danlos syndrome6 as well.
It is known that myxomatous degeneration of the cardiac valves and cystic medionecrosis may be seen in diseases of apparently unrelated etiology, affecting connective tissue, particularly elastic fibers. Thus, in some cases of fibroelastosisll and in the Hurler syndrome,12 myxomatous change in cardiac valves may be seen. Fenestration of aortic cusps, described by Castleman and Sprague: was associated with a similar change in histologic appearance of the aortic cusps. Similar cases were reported by Mathews and Darvill.12 O'Brien and co-workers1* reported two cases of spontaneous aortic cusp rupture, associated with valvular myxomatous transformation. Symbas and colleagues14 described fenestration of aortic cusps in two cases which were the seat of "mucinous de- generation." Their photomicrographs are consistent with myxomatous transformation. Neville and others16 reported nine patients with mitral insufficiency unassociated with the stigmata of the Marfan syndrome, the basis of which was myxomatous degeneration. Review of all these cases, including our own, leads us to conclude that histologic appearance of myxomatous degeneration in cardiac valves can be seen in patients whose only obvious abnormality is in their cardiac valves or in the aorta and cardiac valves.
Experimentally, myxomatous changes of cardiac valves and cystic medionecrosis of the aorta can be produced by giving aminonitriles in rats.18J7 Copper deficient diets produce medionecrosis of the aorta in swine,ls turkeys,le and chicks.20 In turkeys, low protein diet, estrogen administration, or aminonitriles produce medionecrosis. The histologic appearance of medionecrosis in these animals is similar though not identical with that of man. However, increase in myxomatous tissue in the affected aortae is evident. That Merent mechanisms are involved in the production of medionecrosis by different agents is suggested by the fact that collagen abnormality seen in aminonitrile fed rats is not seen in swine fed copper deficient diets.
The support for the concept of nonspecikity of myxomatous change is shown by many older observations, and a recent review published after preparation of this paper.21 M o r i t~, 2~.~~ describing cystic medionecrosis of the aorta, quotes S c h~l t z~~ who believed that myxomatous degeneration was an aging phenomenon seen in animals and man. Castleman and Sprague9 mention myxomatous change in cardiac valves of normal individuals over the age of 30. Our own observations showed that an occasional focus of myxomatous change could be seen in cardiac valves of otherwise normal patients. However, the extent of myxomatous change seen in either group 1 or 2 was never seen unassociated with disease.
Myxomatous transformation of the cardiac valves is not specific to the Marfan syndrome or to the so-called "floppy valve syndrome." It is seen in minor degree in normal valves and in clinical and experimental diseases of unknown etiology. The diEiculties encountered in the treatment of patients with myxomatous degeneration of the cardiac valves9J4~24 are related to friability of aorta and valve annulus.
